Covalon Technologies has announced it has received FDA approval for its IV Clear film dressing, according to a news release.
IV Clear is an antimicrobial silicone adhesive film dressing designed for securing vascular intravenous access devices.
"IV Clear is truly a new innovation in the fight against catheter-related blood stream infections, for which CDC calls one of the most deadly and costly threats to patient safety," said Brian Pedlar, Covalon's CEO, in the release. "Having an antimicrobial silicone adhesive is a clear advantage over the older generation of patches, pads or acrylic adhesive technologies currently available in the market. With over 350 million IV catheter stabilization devices used in the United States alone and the adoption of antimicrobial securement devices experiencing double-digit growth, we fully expect IV Clear to be a strong competitor in the market."
IV Clear is designed to cover and protect insertion sites and to secure intravenous devices to a patient's skin.
FDA approval included the following indications for use: IV catheters, central venous lines, peripherally inserted central catheters, suction catheters, epidural catheters, hemodialysis catheters, orthopedic pins, other intravascular catheters and percutaneous devices.
Covalon is headquartered in Mississauga, Ontario, Canada.
Related Articles on FDA Approvals:
St. Jude Medical Receives FDA Approval for Assura Implantable Defibrillators
Interrad Receives FDA Clearance for Four Additional Sizes of SecurAcath Device
Boston Scientific Announces FDA Approval for New Pacemakers